首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1489204

全球去氧腎上腺素藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Phenylephrine Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球去氧腎上腺素藥物市場需求預計將從 2023 年的 220.5 億美元達到 2032 年近 406.1 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.02%。

去氧腎上腺素藥物是一類用於緩解鼻塞和鼻竇壓力的藥物，這些鼻塞和鼻竇壓力與普通感冒、過敏和鼻竇炎等疾病有關。它們收縮鼻道中的血管，減少腫脹和充血並促進呼吸。這些藥物有多種劑型，包括鼻噴劑、口服片劑和眼藥水，提供了給藥和劑量的靈活性。雖然按照指示使用通常被認為是安全有效的，但這些藥物可能會導致某些人血壓升高、心跳加速和頭痛。它們常見於非處方感冒藥和過敏藥中，可緩解鼻塞和相關症狀。

市場動態

全球鼻塞、鼻竇炎和過敏性鼻炎的盛行率不斷上升，加上感冒、流感和呼吸道感染發病率的上升，推動了對基於去氧腎上腺素的減充血劑作為非處方藥和處方藥的需求。當人們尋求緩解鼻塞和相關症狀時，去氧腎上腺素藥物可以透過縮小鼻道血管並減少腫脹和充血來快速有效地緩解症狀。此外，藥物配方、輸送系統和聯合療法的進步推動了去氧腎上腺素藥物的創新，從而能夠開發緩釋製劑、多症狀緩解產品和兒科友好劑型，以滿足不同患者的需求。

此外，去氧腎上腺素藥物在眼用溶液、口服藥物和心血管支持注射製劑中的不斷擴大應用正在推動市場成長和多樣化。此外，隨著消費者尋求方便易用的解決方案來在家中控制感冒和過敏症狀，對自我照顧、健康和預防性醫療保健的日益關注推動了對非處方去氧腎上腺素產品的需求。然而，替代性減充血藥物的出現以及鼻塞非藥物治療的出現可能會對未來幾年的市場成長構成挑戰。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球去氧腎上腺素藥物市場的每個細分市場進行了包容性評估。去氧腎上腺素藥物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

去氧腎上腺素藥物市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

平板電腦
糖漿
眼藥水
其他

依給藥途徑

口服
注射用
其他

按指示

寒冷的
鼻充血緩解術
過敏反應
眼部疾病
其他

按配銷通路

醫院藥房
藥局和零售藥局
網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲去氧腎上腺素藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。去氧腎上腺素藥物市場的主要參與者包括諾華公司、Perrigo Company PLC、強生消費品公司（Kenvue Inc.）、寶潔公司、輝瑞公司、Foundation Consumer Brands LLC、Mylan NV、Torrent Pharmaceuticals Inc.。克公司、拜耳公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 市場吸引力分析：按產品類型
- 按給藥途徑進行的市場吸引力分析
- 按指標進行的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球去氧腎上腺素藥物市場分析：依產品類型

概述：按產品類型
歷史和預測數據
分析：依產品類型
平板電腦
糖漿
眼藥水
其他

第 6 章：全球去氧腎上腺素藥物市場分析：依給藥途徑

依給藥途徑概述
歷史和預測數據
依給藥途徑分析
口服
注射用
其他

第 7 章：全球去氧腎上腺素藥物市場分析：依適應症分類

按指示概述
歷史和預測數據
按指標分析
寒冷的
鼻充血緩解術
過敏反應
眼部疾病
其他

第 8 章：全球去氧腎上腺素藥物市場分析：按分銷管道

配銷通路概述
歷史和預測數據
按配銷通路分析
醫院藥房
藥局和零售藥局
網路藥局

第 9 章：全球去氧腎上腺素藥物市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：去氧腎上腺素藥品公司的競爭格局

去氧腎上腺素藥物市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Novartis AG

公司簡介
公司收入
產品
最近的發展

Perrigo Company PLC

公司簡介
公司收入
產品
最近的發展

Johnson & Johnson Consumer Inc. (Kenvue Inc.)

公司簡介
公司收入
產品
最近的發展

Proctor & Gamble Co.

公司簡介
公司收入
產品
最近的發展

Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

Foundation Consumer Brands LLC

公司簡介
公司收入
產品
最近的發展

Mylan NV

公司簡介
公司收入
產品
最近的發展

Torrent Pharmaceuticals Inc.

公司簡介
公司收入
產品
最近的發展

GlaxoSmithKline PLC

公司簡介
公司收入
產品
最近的發展

Bayer AG

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114533

The global demand for Phenylephrine Drugs Market is presumed to reach the market size of nearly USD 40.61 Billion by 2032 from USD 22.05 Billion in 2023 with a CAGR of 7.02% under the study period 2024-2032.

Phenylephrine drugs are a class of medications employed to alleviate nasal congestion and sinus pressure linked with conditions like the common cold, allergies, and sinusitis. They constrict blood vessels in the nasal passages, reducing swelling and congestion and facilitating easier breathing. These drugs are available in various formulations, including nasal sprays, oral tablets, and eye drops, providing flexibility in administration and dosage. Though generally regarded as safe and effective when used according to instructions, these drugs may cause elevated blood pressure, rapid heartbeat, and headache in some individuals. They are commonly found in over-the-counter cold and allergy medications, relieving nasal congestion and related symptoms.

MARKET DYNAMICS

The increasing prevalence of nasal congestion, sinusitis, and allergic rhinitis worldwide, coupled with the rising incidence of colds, flu, and respiratory infections, drives demand for phenylephrine-based decongestants as over-the-counter and prescription medications. As individuals seek relief from nasal congestion and related symptoms, phenylephrine drugs offer rapid and effective relief by narrowing nasal passages blood vessels and reducing swelling and congestion. Additionally, advancements in drug formulations, delivery systems, and combination therapies drive innovation in phenylephrine drugs, enabling the development of extended-release formulations, multi-symptom relief products, and pediatric-friendly dosage forms to meet diverse patient needs.

Furthermore, the expanding applications of phenylephrine drugs in ophthalmic solutions, oral medications, and injectable formulations for cardiovascular support are driving market growth and diversification. Moreover, the increasing focus on self-care, wellness, and preventive healthcare drives demand for over-the-counter phenylephrine products as consumers seek convenient and accessible solutions for managing cold and allergy symptoms at home. However, the availability of alternative decongestant medications and the emergence of non-pharmacological treatments for nasal congestion may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Phenylephrine Drugs. The growth and trends of Phenylephrine Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Phenylephrine Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Tablets
Syrups
Eye Drops
Other

By Route Of Administration

Oral
Parenteral
Other

By Indication

Cold
Nasal Decongestion
Allergic Reaction
Eye Disease
Other

By Distribution Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Phenylephrine Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Phenylephrine Drugs market include Novartis AG, Perrigo Company PLC, Johnson & Johnson Consumer Inc. (Kenvue Inc.), Proctor & Gamble Co., Pfizer Inc., Foundation Consumer Brands LLC, Mylan N.V., Torrent Pharmaceuticals Inc., GlaxoSmithKline PLC, Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PHENYLEPHRINE DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Route Of Administration
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data
5.3. Analysis By Product Type
5.4. Tablets Historic and Forecast Sales By Regions
5.5. Syrups Historic and Forecast Sales By Regions
5.6. Eye Drops Historic and Forecast Sales By Regions
5.7. Other Historic and Forecast Sales By Regions

6. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1. Overview By Route Of Administration
6.2. Historical and Forecast Data
6.3. Analysis By Route Of Administration
6.4. Oral Historic and Forecast Sales By Regions
6.5. Parenteral Historic and Forecast Sales By Regions
6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data
7.3. Analysis By Indication
7.4. Cold Historic and Forecast Sales By Regions
7.5. Nasal Decongestion Historic and Forecast Sales By Regions
7.6. Allergic Reaction Historic and Forecast Sales By Regions
7.7. Eye Disease Historic and Forecast Sales By Regions
7.8. Other Historic and Forecast Sales By Regions

8. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data
8.3. Analysis By Distribution Channel
8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
8.5. Drug Stores & Retail Pharmacies Historic and Forecast Sales By Regions
8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL PHENYLEPHRINE DRUGS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PHENYLEPHRINE DRUGS COMPANIES

10.1. Phenylephrine Drugs Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PHENYLEPHRINE DRUGS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Novartis AG
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Perrigo Company PLC
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Johnson & Johnson Consumer Inc. (Kenvue Inc.)
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Proctor & Gamble Co.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Pfizer Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Foundation Consumer Brands LLC
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Mylan N.V.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Torrent Pharmaceuticals Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. GlaxoSmithKline PLC
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Bayer AG
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments